Feng Chi BiotechROCO:6744 +1.30%82 Days Payable is 59.53 as of Dec. 2025, which is 5% above its 10-year median of 56.75. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.84 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 700 Biotechnology companies, Feng Chi Biotech ranks worse than 64% on this metric.
The historical rank and industry rank for Feng Chi Biotech's Days Payable or its related term are showing as below:
ROCO:6744'
s Days Payable Range Over the Past 10 Years
Min: 46.3 Med: 56.75 Max: 70.28
Current: 58.37
During the past 10 years, Feng Chi Biotech's highest Days Payable was 70.28. The lowest was 46.30. And the median was 56.75.
ROCO:6744's Days Payable is ranked worse than 64% of 700
companies
in the Biotechnology industry
Industry Median: 113.1
vs ROCO:6744: 58.37
Feng Chi Biotech's Days Payable
increased
from Dec. 2024 (53.75) to Dec. 2025 (59.53).
It may suggest that Feng Chi Biotechdelayed paying its suppliers.
Feng Chi Biotech Days Payable Related Terms
Feng Chi Biotech Days Payable Historical Data
* Premium members only.
The historical data trend for Feng Chi Biotech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6744 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Feng Chi Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Feng Chi Biotech Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Days Payable distribution charts can be found below:
* The bar in red indicates where Feng Chi Biotech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Feng Chi Biotech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Feng Chi Biotech (ROCO:6744) has a Days Payable of 59.53 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Feng Chi Biotech and its competitors. This is near median its historical median of 56.75. Over the past decade, Feng Chi Biotech's Days Payable has ranged from 46.30 to 70.28. According to the industry distribution chart, Feng Chi Biotech ranks #448 out of 700 companies in the Biotechnology industry, placing it in the top 64%.
Is Feng Chi Biotech's Days Payable too high?
Feng Chi Biotech's current Days Payable of 59.53 is near median its 10-year median of 56.75. Over the past 10 years, this metric has ranged from a low of 46.30 to a high of 70.28. The Biotechnology industry median Days Payable is 113.10. Feng Chi Biotech's value of 59.53 is 47.4% below this industry median. Based on the distribution chart, Feng Chi Biotech ranks #448 out of 700 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Feng Chi Biotech ranks #448 out of 700 companies for Days Payable. This places Feng Chi Biotech in the lower half of its industry. The industry median Days Payable is 113.10. Feng Chi Biotech's value of 59.53 is 47.4% below this benchmark. Historically, Feng Chi Biotech's own Days Payable has ranged from 46.30 to 70.28 over the past decade. While the company's 10-year median is 56.75 vs. the industry median of 113.10, Feng Chi Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Feng Chi Biotech's current Days Payable of 59.53 is 47.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Feng Chi Biotech and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feng Chi Biotech's current Days Payable is 59.53, which is near median its own 10-year median of 56.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.84, compared to a current price of NT$15.60 — trading 25.1% below its estimated fair value. The current Days Payable is 59.53, which is near median its 10-year median of 56.75 and 47.4% below the Biotechnology industry median of 113.10. Feng Chi Biotech's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Days Payable is 59.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?
Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued.
The current stock price of NT$15.60 is trading 25.1% below its estimated GF Value™ of NT$20.84.
GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.
Key valuation signals for ROCO:6744:
Days Payable: 59.53 (near median its 10-year median of 56.75)
GF Value™: NT$20.84 vs. price of NT$15.60 (25.1% below fair value)
Industry Position: 47.4% below the Biotechnology median (#448 of 700)
No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score
Get the complete analysis for ROCO:6744
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6744 has been successfully added to your 
